KEROS THERAPEUTICS INC (KROS) Stock Balance Sheet
NASDAQ:KROS - Nasdaq - US4923271013 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 530.68M | 331.15M | 279.00M | 230.00M | 265.90M | |||
| Receivables | 388.00K | 143.00K | 0.00 | 18.20M | 200.00K | |||
| Other Current Assets | 20.97M | 16.00M | 6.70M | 3.20M | 1.70M | |||
| Total Current Assets | 552.05M | 347.29M | 285.80M | 251.40M | 267.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 24.19M | 19.47M | 17.60M | 2.40M | 1.60M | |||
| Other Non-Current Assets | 3.04M | 3.26M | 3.40M | 1.40M | 100.00K | |||
| Total Non-Current Assets | 27.23M | 22.73M | 21.00M | 3.90M | 1.70M | |||
| TOTAL ASSETS | 579.27M | 370.02M | 306.80M | 255.30M | 269.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 23.67M | 18.26M | 12.50M | 8.00M | 4.80M | |||
| Accounts Payable | 4.98M | 5.45M | 3.30M | 3.60M | 2.10M | |||
| Other Current Liabilities | 354.00K | 665.00K | 700.00K | 200.00K | 200.00K | |||
| Total Current Liabilities | 29.01M | 24.37M | 16.50M | 11.80M | 7.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 17.43M | 13.44M | 12.80M | 200.00K | 500.00K | |||
| Total Non-Current Liabilities | 17.43M | 13.44M | 12.90M | 300.00K | 500.00K | |||
| TOTAL LIABILITIES | 46.44M | 37.81M | 29.40M | 12.10M | 7.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -522.75M | -381.43M | -228.40M | -123.80M | -65.00M | |||
| Additional Paid In Capital | 1.06B | 713.64M | 505.90M | 366.90M | 326.70M | |||
| Common Shares | 4.00K | 3.00K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 39.26M | 31.84M | 27.50M | 24.00M | 23.20M | |||
| Tangible Book Value per Share | 13.57 | 10.43 | 10.09 | 10.13 | 11.28 | |||
| Total Shareholders' Equity | 532.84M | 332.21M | 277.40M | 243.20M | 261.70M | |||
| TOTAL LIABILITIES AND EQUITY | 579.27M | 370.02M | 306.80M | 255.30M | 269.40M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 19.03 | 14.25 | 17.32 | 21.31 | 37.18 | |||
| Return On Assets (ROA) | -31.34% | -41.35% | -34.12% | -23.01% | -16.84% | |||
| Return On Equity (ROE) | -34.08% | -46.05% | -37.74% | -24.15% | -17.33% | |||
All data in USD , ROIC based on taxRate of 0.21